The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2015

Filed:

Jun. 26, 2012
Applicants:

Brian D. Burkinshaw, Pflugerville, TX (US);

Steven I. Whitlock, Austin, TX (US);

Kevin Pauza, Tyler, TX (US);

Mark I. Richards, Leander, TX (US);

James B. Rogan, Austin, TX (US);

Inventors:

Brian D. Burkinshaw, Pflugerville, TX (US);

Steven I. Whitlock, Austin, TX (US);

Kevin Pauza, Tyler, TX (US);

Mark I. Richards, Leander, TX (US);

James B. Rogan, Austin, TX (US);

Assignee:

BSNC Holding, LLC, Pflugerville, TX (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 17/56 (2006.01); A61L 27/54 (2006.01); A61B 17/00 (2006.01); A61K 38/36 (2006.01); A61K 38/48 (2006.01); A61K 45/06 (2006.01); A61L 24/10 (2006.01); A61L 27/22 (2006.01); A61L 27/50 (2006.01);
U.S. Cl.
CPC ...
A61L 27/54 (2013.01); A61B 17/00491 (2013.01); A61B 17/0057 (2013.01); A61K 38/363 (2013.01); A61K 38/482 (2013.01); A61K 45/06 (2013.01); A61L 24/106 (2013.01); A61L 27/225 (2013.01); A61L 27/50 (2013.01); A61B 2017/00495 (2013.01); A61L 2300/00 (2013.01); A61L 2400/06 (2013.01); A61L 2430/38 (2013.01);
Abstract

A method of treating a disc that is leaking nucleus pulposus through at least one defect in the annulus fibrosus. The method includes injecting a fibrin sealant into the disc to reduce at least a portion of the at least one defect, wherein the fibrin sealant injected into the disc comprises fibrinogen and an activating compound, wherein at least a portion of the fibrin forms after injection, wherein the fibrinogen, the activating compound or both has been reconstituted with a solution containing at least one additive, with the proviso that a corticosteroid is absent from the fibrin sealant injected into the disc.


Find Patent Forward Citations

Loading…